New study aims to uncover hidden muscle loss in arthritis patients

NCT ID NCT03319264

Completed Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how common muscle loss (sarcopenia) is in people with spondylarthropathy, a type of inflammatory arthritis. Researchers will measure muscle strength, walking speed, and body composition in 106 adults. The goal is to better understand and detect this disabling condition, which is not well studied in France.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better detect and manage muscle loss in people with spondylarthropathy, potentially reducing falls and fractures.
What could go wrong: This is an observational study with no treatment being tested. It only measures current muscle health and cannot show whether any intervention works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sarcopenia Spondylarthropathies spondyloarthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARCOPENIA SPONDYLARTHROPATHY

Contacts and locations

Show contact details

Locations

Service de Rhumatologie - Hôpital Edouard Herriot

Lyon, 69003, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.